Insider Transactions in Q2 2025 at Aziyo Biologics, Inc. (AZYO)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 21
2025
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,019
-2.44%
|
$8,019
$1.81 P/Share
|
|
Jun 21
2025
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,473
+6.39%
|
-
|
|
Jun 10
2025
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
3,951
-4.45%
|
$3,951
$1.99 P/Share
|
|
Jun 10
2025
|
Michelle Le Roux Williams CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+12.34%
|
-
|
|
Jun 10
2025
|
C Randal Mills PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,664
-3.05%
|
$9,664
$1.99 P/Share
|
|
Jun 10
2025
|
C Randal Mills PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
27,084
+7.89%
|
-
|
|
Jun 10
2025
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,461
-1.26%
|
$4,461
$1.99 P/Share
|
|
Jun 10
2025
|
Matthew Ferguson CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+3.4%
|
-
|